Follow
Ken Miles
Ken Miles
Verified email at ucl.ac.uk
Title
Cited by
Cited by
Year
Imaging biomarker roadmap for cancer studies
JPB O'connor, EO Aboagye, JE Adams, HJWL Aerts, SF Barrington, ...
Nature reviews Clinical oncology 14 (3), 169-186, 2017
10792017
Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?
F Davnall, CSP Yip, G Ljungqvist, M Selmi, F Ng, B Sanghera, ...
Insights into imaging 3, 573-589, 2012
9362012
Measurement of tissue perfusion by dynamic computed tomography
KA Miles
The British journal of radiology 64 (761), 409-412, 1991
7621991
Perfusion CT: a worthwhile enhancement?
KA Miles, MR Griffiths
The British journal of radiology 76 (904), 220-231, 2003
7542003
Functional images of hepatic perfusion obtained with dynamic CT.
KA Miles, MP Hayball, AK Dixon
Radiology 188 (2), 405-411, 1993
6681993
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
B Ganeshan, E Panayiotou, K Burnand, S Dizdarevic, K Miles
European radiology 22, 796-802, 2012
5522012
Perfusion CT for the assessment of tumour vascularity: which protocol?
KA Miles
The British journal of radiology 76 (suppl_1), S36-S42, 2003
5292003
Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review
KA Miles
European journal of radiology 30 (3), 198-205, 1999
5241999
Non–small cell lung cancer: histopathologic correlates for texture parameters at CT
B Ganeshan, V Goh, HC Mandeville, QS Ng, PJ Hoskin, KA Miles
Radiology 266 (1), 326-336, 2013
5022013
Colour perfusion imaging: a new application of computed tomography
KA Miles, M Hayball, AK Dixon
The Lancet 337 (8742), 643-645, 1991
4911991
Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival
F Ng, B Ganeshan, R Kozarski, KA Miles, V Goh
Radiology 266 (1), 177-184, 2013
4722013
Percutaneous transluminal angioplasty of occlusions of the femoral and popliteal arteries by subintimal dissection
A Bolia, KA Miles, J Brennan, PRF Bell
Cardiovascular and interventional radiology 13, 357-363, 1990
4561990
Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker
V Goh, B Ganeshan, P Nathan, JK Juttla, A Vinayan, KA Miles
Radiology 261 (1), 165-171, 2011
3962011
Quantifying tumour heterogeneity with CT
B Ganeshan, KA Miles
Cancer imaging 13 (1), 140, 2013
3882013
Application of CT in the investigation of angiogenesis in oncology
KA Miles, C Charnsangavej, FT Lee, EK Fishman, K Horton, TY Lee
Academic radiology 7 (10), 840-850, 2000
3802000
Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage
B Ganeshan, S Abaleke, RCD Young, CR Chatwin, KA Miles
Cancer imaging 10 (1), 137, 2010
3712010
Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival
B Ganeshan, K Skogen, I Pressney, D Coutroubis, K Miles
Clinical radiology 67 (2), 157-164, 2012
3452012
Functional computed tomography in oncology
KA Miles
European Journal of Cancer 38 (16), 2079-2084, 2002
344*2002
CT texture analysis using the filtration-histogram method: what do the measurements mean?
KA Miles, B Ganeshan, MP Hayball
Cancer Imaging 13 (3), 400, 2013
3132013
Colorectal Cancer: Texture Analysis of Portal Phase Hepatic CT Images as a Potential Marker of Survival1
KA Miles, B Ganeshan, MR Griffiths, RCD Young, CR Chatwin
Radiology 250 (2), 444-452, 2009
2842009
The system can't perform the operation now. Try again later.
Articles 1–20